Pubblicazioni scientifiche

Cancella testo

Open Access

1193 pubblicazioni

Buti S.; Ciccarese C.; Iacovelli R.; Bersanelli M.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Montironi R.; Tortora G.; Massari F., Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 - Prostate and bladder cancer, «FUTURE ONCOLOGY», 2016, 12, pp. 1971 - 1974 [Articolo in rivista]
Ciccarese C.; Massari F.; Tortora G., Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?, «EUROPEAN UROLOGY», 2016, 69, pp. 969 - 970 [Articolo in rivista]
Montironi R.; Santoni M.; Sotte V.; Cheng L.; Lopez-Beltran A.; Massari F.; Matrana M.R.; Moch H.; Berardi R.; Scarpelli M., Emerging immunotargets and immunotherapies in prostate cancer, «CURRENT DRUG TARGETS», 2016, 17, pp. 777 - 782 [Articolo in rivista]
Ciccarese C.; Santoni M.; Massari F., Chemohormonal therapy in hormone-sensitive prostate cancer, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2016, 374, pp. 286 - 287 [Articolo in rivista]
Massari F.; Modena A.; Ciccarese C.; Pilotto S.; Maines F.; Bracarda S.; Sperduti I.; Giannarelli D.; Carlini P.; Santini D.; Tortora G.; Porta C.; Bria E., Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2016, 98, pp. 254 - 263 [Articolo in rivista]
Mazzucchelli R.; Gasparrini S.; Galosi A.B.; Massari F.; Raspollini M.R.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Montironi R., Genitourinary cancers: molecular determinants for personalized therapies, «UROLOGIA», 2016, 83, pp. 107 - 109 [Articolo in rivista]
Kucharczyk J.; Matrana M.R.; Santoni M.; Massari F.; Scarpelli M.; Cheng L.; Lopez-Beltran A.; Cascinu S.; Montironi R.; Holger M., Emerging immunotargets in metastatic renal cell carcinoma, «CURRENT DRUG TARGETS», 2016, 17, pp. 771 - 776 [Articolo in rivista]
Montironi R.; Santoni M.; Massari F.; Lopez-Beltran A.; Cheng L.; Berardi R.; Scarpelli M., Emerging immunotargets in genitourinary tumors, «CURRENT DRUG TARGETS», 2016, 17, pp. 748 - 749 [Articolo in rivista]
Ciccarese C.; Santoni M.; Massari F.; Modena A.; Piva F.; Conti A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Tortora G.; Montironi R., Metabolic alterations in renal and prostate cancer, «CURRENT DRUG METABOLISM», 2016, 17, pp. 150 - 155 [Articolo in rivista]
Conteduca V.; Crabb S.J.; Jones R.J.; Caffo O.; Elliott T.; Scarpi E.; Fabbri P.; Derosa L.; Massari F.; Numico G.; Zarif S.; Hanna C.; Maines F.; Joyce H.; Lolli C.; De Giorgi U., Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer, «PLOS ONE», 2016, 11, pp. 1 - 12 [Articolo in rivista]
Schepisi G.; Santoni M.; Massari F.; Gurioli G.; Salvi S.; Conteduca V.; Montironi R.; De Giorgi U., Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy, «BIODRUGS», 2016, 30, pp. 263 - 273 [Articolo in rivista]
Ciccarese C.; Massari F.; Tortora G., 2015 and human cancer: Back to overall survival, «FUTURE ONCOLOGY», 2016, 12, pp. 1751 - 1754 [Articolo in rivista]
Massari F.; Ciccarese C.; Calio A.; Munari E.; Cima L.; Porcaro A.B.; Novella G.; Artibani W.; Sava T.; Eccher A.; Ghimenton C.; Bertoldo F.; Scarpa A.; Sperandio N.; Porta C.; Bronte V.; Chilosi M.; Bogina G.; Zamboni G.; Tortora G.; Samaratunga H.; Martignoni G.; Brunelli M., Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis, «TARGETED ONCOLOGY», 2016, 11, pp. 345 - 351 [Articolo in rivista]
Santoni M.; Massari F., mTOR Pathway in Renal Cell Carcinoma, «Molecules to Medicine with mTOR. Translating Critical Pathways Into Novel Therapeutic Strategies», 2016, 1, pp. 417 - 428 [Articolo in rivista]
Buti S.; Ciccarese C.; Iacovelli R.; Bersanelli M.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Montironi R.; Tortora G.; Massari F., Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 1 - Kidney cancer, «FUTURE ONCOLOGY», 2016, 12, pp. 1967 - 1970 [Articolo in rivista]
Modena A.; Iacovelli R.; Scarpa A.; Brunelli M.; Ciccarese C.; Fantinel E.; Bimbatti D.; Massari F.; Martignoni G.; Tortora G., Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer, «TARGETED ONCOLOGY», 2016, 11, pp. 569 - 577 [Articolo in rivista]
Gelati C, Negosanti L, Pinto V, Sgarzani R, Cipriani R, Aesthetic Outcome After Breast Reconstruction Using Deep Inferior Epigastric Artery Perforator Flap, in: Shiffman Melvin A, Breast Reconstruction: Art, Science and New Clinical Techniques, Cham, Springer International Publishing, 2016, pp. 1237 - 1245 [Capitolo/Saggio in libro]
R Sgarzani, L Negosanti, S Tedeschi, R Capirossi, R Cipriani, "MRI, culture of swab specimen and two stage surgery in spinal cord injury patients with pressure sores", in: 27th EURAPS (European Association of Plastic Surgeons) Annual Meeting, 2016, pp. 187 - 187 (atti di: 27th EURAPS (European Association of Plastic Surgeons) Annual Meeting., Bruxelles, Belgio, 26-05-2016) [Riassunto (Abstract)]
I. J. Fernandez, P. Farneti, F. Crocetta, E. Pasquini, V. Sciarretta, Micosi invasive naso-sinusali, in: EVOLUZIONE ED INNOVAZIONE NELLA GESTIONE DELLA PATOLOGIA RINOSINUSALE, Galatina (LE), Torgraf, 2016, pp. 267 - 288 [Capitolo/Saggio in libro]
Saraceni, Francesco; Agostini, Vanessa; Vincenzi, Daniele; Lanza, Francesco, Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at?, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2016, 2016, pp. 85 - 94 [Articolo in rivista]